{
  "issues": [
    "Missing patient weight and height prevents accurate calculation of BMI and weight‑based contrast dose.",
    "Patient is hypotensive (SBP 82 mmHg, MAP 59 mmHg), increasing risk of contrast‑induced renal injury and potentially limiting safe contrast administration.",
    "Renal tool flagged elevated creatinine (1.7 mg/dL) and moderate eGFR (59 mL/min/1.73m2) – a moderate renal risk category that requires explicit prophylaxis.",
    "Renal tool summary mentions missing BMI and lack of lab timestamps, indicating incomplete data capture for renal safety monitoring.",
    "Agent 2’s recommendation to proceed with CTPA does not explicitly address the need for hemodynamic stabilization prior to contrast administration."
  ],
  "recommendations": [
    "Obtain the patient’s weight and height immediately; calculate BMI to guide contrast volume and document for future renal safety tracking.",
    "Stabilize hemodynamics before contrast: consider a fluid bolus of isotonic saline (e.g., 250‑500 mL) if not contraindicated, and use vasopressors as needed to achieve SBP >90 mmHg and MAP >65 mmHg.",
    "Limit contrast volume to the lowest feasible amount: e.g., 0.8–1.0 mL/kg (≈50‑70 mL for an average 70‑kg adult) using low‑osmolar or iso‑osmolar iodinated contrast, and avoid the maximum 100 mL dose suggested in the protocol.",
    "Implement a renal protection protocol: pre‑hydration with isotonic saline 1 mL/kg/hour for 3‑4 hours before and 1‑2 hours after contrast (adjusted for fluid status), consider N‑acetylcysteine only if institutional policy supports it.",
    "If hemodynamic goals cannot be achieved or the patient remains unstable, switch to a ventilation‑perfusion (V/Q) scan as the primary imaging modality for pulmonary embolism.",
    "Document all renal safety metrics (eGFR, creatinine, BUN/Cr ratio, BMI, contrast volume, hydration regimen) with timestamps in the electronic health record.",
    "Update the protocol selection to reflect a modified contrast dose and hydration plan tailored to moderate renal impairment and hypotension.",
    "Re‑run the renal decision‑support tool after weight/height are entered and after hemodynamic stabilization to verify that the ‘overall’ status changes to pass or warning rather than fail."
  ],
  "confidence": 0.71,
  "agent2_confidence": 0.78,
  "timestamp": "2025-09-09T06:07:39.565018Z",
  "tool_outputs": {
    "renal": {
      "tool_id": "renal_tool_v2",
      "checks": [
        {
          "id": "egfr_ckd_epi",
          "units": "ml/min/1.73m2",
          "timestamp": "2025-09-09T06:07:04.655020Z",
          "priority": "critical",
          "value": 59.0,
          "status": "pass",
          "reason": "Low renal risk for contrast."
        },
        {
          "id": "creatinine_mg_dl",
          "units": "mg/dL",
          "timestamp": "2025-09-09T06:07:04.655036Z",
          "priority": "critical",
          "value": 1.7,
          "status": "fail",
          "reason": "Creatinine significantly elevated."
        },
        {
          "id": "bun_creatinine_ratio",
          "timestamp": "2025-09-09T06:07:04.655043Z",
          "priority": "important",
          "value": 20.0,
          "status": "warning",
          "reason": "BUN/Cr ratio suggests prerenal azotemia."
        },
        {
          "id": "potassium_mmol_l",
          "units": "mEq/L",
          "timestamp": "2025-09-09T06:07:04.655056Z",
          "priority": "important",
          "value": 4.6,
          "status": "pass",
          "reason": "Potassium normal."
        }
      ],
      "summary": {
        "overall": "fail",
        "reasons": [
          "Creatinine significantly elevated.",
          "BUN/Cr ratio suggests prerenal azotemia.",
          "Missing BMI or creatinine.",
          "No lab timestamps provided."
        ],
        "confidence": 0.52
      },
      "metadata": {
        "version": "2.0.0",
        "run_ts": "2025-09-09T06:07:04.655093Z"
      }
    }
  },
  "llm_raw": "{\n  \"issues\": [\n    \"Missing patient weight and height prevents accurate calculation of BMI and weight‑based contrast dose.\",\n    \"Patient is hypotensive (SBP 82 mmHg, MAP 59 mmHg), increasing risk of contrast‑induced renal injury and potentially limiting safe contrast administration.\",\n    \"Renal tool flagged elevated creatinine (1.7 mg/dL) and moderate eGFR (59 mL/min/1.73m2) – a moderate renal risk category that requires explicit prophylaxis.\",\n    \"Renal tool summary mentions missing BMI and lack of lab timestamps, indicating incomplete data capture for renal safety monitoring.\",\n    \"Agent 2’s recommendation to proceed with CTPA does not explicitly address the need for hemodynamic stabilization prior to contrast administration.\"\n  ],\n  \"recommendations\": [\n    \"Obtain the patient’s weight and height immediately; calculate BMI to guide contrast volume and document for future renal safety tracking.\",\n    \"Stabilize hemodynamics before contrast: consider a fluid bolus of isotonic saline (e.g., 250‑500 mL) if not contraindicated, and use vasopressors as needed to achieve SBP >90 mmHg and MAP >65 mmHg.\",\n    \"Limit contrast volume to the lowest feasible amount: e.g., 0.8–1.0 mL/kg (≈50‑70 mL for an average 70‑kg adult) using low‑osmolar or iso‑osmolar iodinated contrast, and avoid the maximum 100 mL dose suggested in the protocol.\",\n    \"Implement a renal protection protocol: pre‑hydration with isotonic saline 1 mL/kg/hour for 3‑4 hours before and 1‑2 hours after contrast (adjusted for fluid status), consider N‑acetylcysteine only if institutional policy supports it.\",\n    \"If hemodynamic goals cannot be achieved or the patient remains unstable, switch to a ventilation‑perfusion (V/Q) scan as the primary imaging modality for pulmonary embolism.\",\n    \"Document all renal safety metrics (eGFR, creatinine, BUN/Cr ratio, BMI, contrast volume, hydration regimen) with timestamps in the electronic health record.\",\n    \"Update the protocol selection to reflect a modified contrast dose and hydration plan tailored to moderate renal impairment and hypotension.\",\n    \"Re‑run the renal decision‑support tool after weight/height are entered and after hemodynamic stabilization to verify that the ‘overall’ status changes to pass or warning rather than fail.\"\n  ],\n  \"confidence\": 0.71\n}",
  "hallucination_analysis": {
    "statement_assessments": [
      {
        "text": "Missing patient weight and height prevents accurate calculation of BMI and weight‑based contrast dose.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Patient is hypotensive (SBP 82 mmHg, MAP 59 mmHg), increasing risk of contrast‑induced renal injury and potentially limiting safe contrast administration.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Renal tool flagged elevated creatinine (1.7 mg/dL) and moderate eGFR (59 mL/min/1.73m2) – a moderate renal risk category that requires explicit prophylaxis.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Renal tool summary mentions missing BMI and lack of lab timestamps, indicating incomplete data capture for renal safety monitoring.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Agent 2’s recommendation to proceed with CTPA does not explicitly address the need for hemodynamic stabilization prior to contrast administration.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Obtain the patient’s weight and height immediately; calculate BMI to guide contrast volume and document for future renal safety tracking.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Stabilize hemodynamics before contrast: consider a fluid bolus of isotonic saline (e.g., 250‑500 mL) if not contraindicated, and use vasopressors as needed to achieve SBP >90 mmHg and MAP >65 mmHg.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact '0'"
      },
      {
        "text": "Limit contrast volume to the lowest feasible amount: e.g., 0.8–1.0 mL/kg (≈50‑70 mL for an average 70‑kg adult) using low‑osmolar or iso‑osmolar iodinated contrast, and avoid the maximum 100 mL dose suggested in the protocol.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact '0'"
      },
      {
        "text": "Implement a renal protection protocol: pre‑hydration with isotonic saline 1 mL/kg/hour for 3‑4 hours before and 1‑2 hours after contrast (adjusted for fluid status), consider N‑acetylcysteine only if institutional policy supports it.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "If hemodynamic goals cannot be achieved or the patient remains unstable, switch to a ventilation‑perfusion (V/Q) scan as the primary imaging modality for pulmonary embolism.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Document all renal safety metrics (eGFR, creatinine, BUN/Cr ratio, BMI, contrast volume, hydration regimen) with timestamps in the electronic health record.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Update the protocol selection to reflect a modified contrast dose and hydration plan tailored to moderate renal impairment and hypotension.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Re‑run the renal decision‑support tool after weight/height are entered and after hemodynamic stabilization to verify that the ‘overall’ status changes to pass or warning rather than fail.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      }
    ],
    "counts": {
      "supported": 13,
      "inferred": 0,
      "domain_safe": 0,
      "unverified": 0,
      "contradicted": 0
    },
    "hallucination_score": 0.0,
    "recommendation": {
      "force_revision": false,
      "confidence_reduction": 0.0
    },
    "knowledge_base_summary": {
      "numbers": {
        "subject_id": 20028931.0,
        "age": 72.0,
        "hadm_id": 34567891.0,
        "creatinine_mg_dl": 1.7,
        "bun_mg_dl": 34.0,
        "glucose_mg_dl": 142.0,
        "hemoglobin_g_dl": 10.1,
        "hematocrit_pct": 30.5,
        "platelet_count": 210.0,
        "wbc_count": 12.3,
        "sodium_meq_l": 135.0,
        "potassium_mmol_l": 4.6,
        "chloride_meq_l": 100.0,
        "bicarbonate_meq_l": 21.0,
        "egfr_ckd_epi": 59.0,
        "heart_rate_bpm": 95.0,
        "systolic_bp_mmhg": 82.0,
        "diastolic_bp_mmhg": 48.0,
        "map_mmhg": 59.0,
        "pulse_pressure_mmhg": 34.0,
        "temperature_f": 98.9,
        "spo2_pct": 94.0,
        "respiratory_rate": 22.0,
        "bun_creatinine_ratio": 20.0,
        "hospital_expire_flag": 0.0,
        "data_completeness_pct": 0.95
      },
      "raw_strings_sample": [
        "white",
        "0",
        "21",
        "f",
        "30.5",
        "1.7",
        "other",
        "95",
        "20.0",
        "potassium_mmol_l"
      ]
    }
  },
  "feedback": {
    "issues": [
      "Missing patient weight and height prevents accurate calculation of BMI and weight‑based contrast dose.",
      "Patient is hypotensive (SBP 82 mmHg, MAP 59 mmHg), increasing risk of contrast‑induced renal injury and potentially limiting safe contrast administration.",
      "Renal tool flagged elevated creatinine (1.7 mg/dL) and moderate eGFR (59 mL/min/1.73m2) – a moderate renal risk category that requires explicit prophylaxis.",
      "Renal tool summary mentions missing BMI and lack of lab timestamps, indicating incomplete data capture for renal safety monitoring.",
      "Agent 2’s recommendation to proceed with CTPA does not explicitly address the need for hemodynamic stabilization prior to contrast administration."
    ],
    "recommendations": [
      "Obtain the patient’s weight and height immediately; calculate BMI to guide contrast volume and document for future renal safety tracking.",
      "Stabilize hemodynamics before contrast: consider a fluid bolus of isotonic saline (e.g., 250‑500 mL) if not contraindicated, and use vasopressors as needed to achieve SBP >90 mmHg and MAP >65 mmHg.",
      "Limit contrast volume to the lowest feasible amount: e.g., 0.8–1.0 mL/kg (≈50‑70 mL for an average 70‑kg adult) using low‑osmolar or iso‑osmolar iodinated contrast, and avoid the maximum 100 mL dose suggested in the protocol.",
      "Implement a renal protection protocol: pre‑hydration with isotonic saline 1 mL/kg/hour for 3‑4 hours before and 1‑2 hours after contrast (adjusted for fluid status), consider N‑acetylcysteine only if institutional policy supports it.",
      "If hemodynamic goals cannot be achieved or the patient remains unstable, switch to a ventilation‑perfusion (V/Q) scan as the primary imaging modality for pulmonary embolism.",
      "Document all renal safety metrics (eGFR, creatinine, BUN/Cr ratio, BMI, contrast volume, hydration regimen) with timestamps in the electronic health record.",
      "Update the protocol selection to reflect a modified contrast dose and hydration plan tailored to moderate renal impairment and hypotension.",
      "Re‑run the renal decision‑support tool after weight/height are entered and after hemodynamic stabilization to verify that the ‘overall’ status changes to pass or warning rather than fail."
    ],
    "confidence": 0.71
  }
}